APA (7th ed.) Citation

Terheyden, J., Schmitz-Valckenberg, S., Crabb, D., Dunbar, H., Luhmann, U., Behning, C., . . . Finger, R. (2021). Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions. Ophthalmologica (Basel), 244(5), 387-395. https://doi.org/10.1159/000513591

Chicago Style (17th ed.) Citation

Terheyden, Jan Henrik, et al. "Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions." Ophthalmologica (Basel) 244, no. 5 (2021): 387-395. https://doi.org/10.1159/000513591.

MLA (9th ed.) Citation

Terheyden, Jan Henrik, et al. "Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions." Ophthalmologica (Basel), vol. 244, no. 5, 2021, pp. 387-395, https://doi.org/10.1159/000513591.